Table 2.
RCT | Non-RCT | Total | |
---|---|---|---|
Progression-free survival | 13 (8%) | 85 (51%) | 98 (59%) |
Overall survival | 11 (7%) | 34 (20%) | 45 (27%) |
Safety/toxicity/MTD | 7 (4%) | 19 (11%) | 26 (16%) |
Imaging/response | 3 (2%) | 28 (17%) | 31 (19%) |
PK/PD | 2 (1%) | 5 (3%) | 7 (4%) |
Other | 4 (2%) | 4 (2%) | |
Total | 25 (15%) | 141 (85%) | 166 (100%) |